Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Nasal Spray for Panic Attacks
NCT07162649Completed
- Sponsor
- Tongji University
- Start
- Jun 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in panic disorder comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: 30-minute response rate using Clinical Global Impression-Efficacy Index (CGI-EI). Started Jun 2025; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT07162649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07162649.